PPT Slide

VaxGen’s NIAID Anthrax Vaccine Contracts

• $20.9 million value

• 2,000 dose inventory (completed)

• Phase I clinical trial

• Plans for supply of 25 mm doses

Oct.

2003

• $80.3 million value

• Conduct two Phase II trials and animal studies

• Manufacturing scale-up and validation

• Supply 3 million dose inventory to NIH

Oct.

2002

Previous slide

Next slide

Back to first slide

View graphic version